Daratumumab as rescue therapy in life-threatening granulomatosis with polyangiitis (2024) Krusche M, Oqueka T, Wichmann D, Kluge S, Huber TB, Kötter I, Schmidt-Lauber C Journal article Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study. (2024) Kaeley GS, Schett G, Conaghan PG, McGonagle D, Behrens F, Goupille P, Gaillez C, et al. Journal article Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies (2024) Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kleyer A, Gary R, et al. Journal article, Letter Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study. (2024) Ziade N, Aoude M, Hmamouchi I, Naveen R, Lilleker JB, Sen P, Joshi M, et al. Journal article Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease. (2024) Györfi AH, Filla T, Dickel N, Möller F, Li YN, Bergmann C, Matei AE, et al. Journal article COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. (2024) Andreoli L, Lini D, Schreiber K, Parodis I, Sen P, Ravichandran N, Day J, et al. Journal article Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study. (2024) Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, et al. Journal article Enhancing student understanding of rheumatic disease pathologies through augmented reality: findings from a multicentre trial. (2024) Pfeil A, Klemm P, Hueber AJ, Hoffmann T, Weise T, Oelzner P, Knop S, et al. Journal article Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys (2023) Jagtap K, Naveen R, Day J, Sen P, Vaidya B, Nune A, Nikiphorou E, et al. Journal article Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study (2023) Ali SS, Naveen R, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article